Peripartum cardiomyopathy: A contemporary review

Journal of Clinical and Preventive Cardiology

关键词: Cardiomyopathy;    dilated cardiomyopathy;    heart failure;    reduced ejection fraction;   

DOI  :  10.4103/JCPC.JCPC_8_18

来源: DOAJ

【 摘 要 】

Peripartum cardiomyopathy (PPCM) is a rare, potentially life-threatening disorder affecting women in late pregnancy and the postpartum period. Historically, PPCM was not recognized as a separate disease entity until the 1930s. Further research has since led to the identification of at-risk demographics, theories on etiology, and new targets of therapy. Management to date has largely been focused on guideline-based treatment for heart failure with reduced ejection fraction. However, newer studies have shown the efficacy of novel therapies. In this article, we will review the pathogenesis and diagnosis of PPCM and conclude with some of the newest therapies being offered.

【 授权许可】

Unknown